Lyra Therapeutics, Inc.
NASDAQ:LYRA
0.172 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 40.577 | 22.353 | 32.55 | 45.747 | 74.593 | 9.808 | 23.888 |
| Short Term Investments
| 0 | 80.4 | 65.344 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 40.577 | 102.753 | 97.894 | 45.747 | 74.593 | 9.808 | 23.888 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0.167 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 2.448 | 2.068 | 2.935 | 4.342 | 2.648 | 0.311 | 0.872 |
| Total Current Assets
| 43.025 | 104.821 | 100.829 | 47.918 | 75.917 | 10.119 | 24.927 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 21.328 | 35.276 | 4.466 | 5.858 | 4.466 | 3.419 | 0.103 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 1.392 | 0.329 | 0.329 | 0.329 | 0.329 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.993 | 2.503 | 3.281 | 0.762 | 0.118 | 1.096 | 0 |
| Total Non-Current Assets
| 23.321 | 37.779 | 9.139 | 6.949 | 4.913 | 4.844 | 0.432 |
| Total Assets
| 66.346 | 142.6 | 109.968 | 54.867 | 80.83 | 14.963 | 25.359 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 1.179 | 3.131 | 2.616 | 3.125 | 0.922 | 1.069 | 0.631 |
| Short Term Debt
| 4.121 | 8.907 | 3.51 | 2.148 | 1.97 | 0.899 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0.398 | 1.658 | 1.275 | 9.789 | 2.828 | 3.13 | 0 |
| Other Current Liabilities
| 6.933 | 9.374 | 9.03 | 3.184 | 1.992 | 3.24 | 1.329 |
| Total Current Liabilities
| 12.631 | 19.597 | 14.47 | 18.246 | 4.884 | 5.208 | 1.96 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 30.259 | 21.447 | 0.667 | 0.379 | 1.454 | 2.427 | 0 |
| Deferred Revenue Non-Current
| 0 | 12.136 | 14.077 | 1.926 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | -14.077 | -1.926 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 11.862 | 0 | 0 | 0 | 0 | 0 | 130.473 |
| Total Non-Current Liabilities
| 42.121 | 33.583 | 14.744 | 2.305 | 1.454 | 2.427 | 130.473 |
| Total Liabilities
| 54.752 | 53.18 | 29.214 | 20.551 | 6.338 | 7.635 | 132.433 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 80.83 | 130.666 | 130.353 |
| Common Stock
| 0.065 | 0.057 | 0.032 | 0.013 | 0.013 | 0.006 | 0.006 |
| Retained Earnings
| -404.79 | -311.355 | -248.675 | -193.397 | -149.884 | -127.757 | -111.451 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0.033 | 0.01 | 0 | -80.83 | 0 | -2.802 |
| Other Total Stockholders Equity
| 416.319 | 400.685 | 329.387 | 227.7 | 305.193 | 4.419 | -127.551 |
| Total Shareholders Equity
| 11.594 | 89.42 | 80.754 | 34.316 | 74.492 | 7.328 | -107.074 |
| Total Equity
| 11.594 | 89.42 | 80.754 | 34.316 | 74.492 | 7.328 | -107.074 |
| Total Liabilities & Shareholders Equity
| 66.346 | 142.6 | 109.968 | 54.867 | 80.83 | 14.963 | 25.359 |